Trial intelligence / Profile preview

Cannabidiol in Stress Regulation

NCT07278505Phase 2Recruiting

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Oct 2025
Primary completion
Feb 2030
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cannabidiol in stress, sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2025; status: recruiting.

02

Drugs

cannabidiol
03

Conditions

stress

Beyond the preview

Go deeper on NCT07278505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07278505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call